Skip to content
Screener

IQVIA IQV Q3 2026 earnings

Reported October 27, 2026 · Before market open

Revenue$4.4BBeat by $62.8M
Adjusted EPS$3.34Beat by $0.08
Revenue estimate$4.4B
EPS estimate$3.26
“IQVIA delivered another record quarter, with revenue, Adjusted EBITDA and Adjusted Diluted EPS all exceeding the high end of our expectations. Multiple demand indicators continue to validate the strengthening market environment. EBP funding, RFP flow, clinical trial starts, FDA approvals, outsourcing trends, and pipeline growth across clinical and commercial are all favorable. At the same time, the team's ongoing excellent execution delivered margin expansion, strong free cash flow, higher win rates that resulted in our strongest clinical quarterly bookings since 2022, increased penetration of AI-powered solutions with over 400 AI agents deployed to date, and organic growth acceleration year-over-year to double the rate for commercial and nearly triple the rate for clinical.”
Ari Bousbib

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$4.4B+8.0%
Gross profit$1.5B+9.1%
Operating income$572.0M+3.4%
Net income$350.0M+5.7%
EPS (diluted)$2.10+8.8%

Balance sheet

See full
Cash & equivalents$2.2B+24.0%
Total debt$16.3B+7.4%
Total equity$6.7B+8.1%
Total assets$30.5B+6.1%

Cash flow

See full
Operating cash flow$825.0M-9.1%
CapEx$158.0M+16.2%
Free cash flow$667.0M-13.6%

Valuation & ratios

Valuation

as of 10/27/26
See full
Market cap$45.98B+21.8%
Enterprise value$60.05B+17.4%
P/E33×+3.6×
P/S2.7×+0.3×

Profitability

See full
Gross margin33.1%-0.7pp
Operating margin12.8%-0.9pp
Net margin8.1%0.0pp
FCF margin12%-1.9pp

Returns & leverage

See full
Return on equity21.7%+2.2pp
Debt / equity2.4×0.0×
Current ratio0.8×+0.1×

Segments

By segment

See full
Research & Development Solutions$2.6B+16.8%
Commercial Solutions$1.8B—
Technology And Analytics Solutions$1.8B+9.7%

By geography

See full
Americas$2.1B+8.0%
Europe and Africa$1.4B+9.3%
Asia-Pacific$924.0M+6.2%

FAQ

When did IQVIA report Q3 2026 earnings?
IQVIA (IQV) reported Q3 2026 earnings on October 27, 2026 before market open.
What were IQVIA's Q3 2026 revenue and EPS?
IQVIA reported revenue of $4.4B and adjusted eps of $3.34 for Q3 2026.
Did IQVIA beat estimates in Q3 2026?
Revenue beat the consensus estimate of $4.4B by $62.8M. EPS beat the consensus estimate of $3.26 by $0.08.
How did IQVIA's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.0% from $4.1B a year earlier.
Where can I find IQVIA's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-067406) and the 10-Q periodic report (0001628280-26-067646) directly on SEC EDGAR. The filing index links above go to sec.gov.